Archives for May 2007
Axxora Deal Boosts Enzo’s International Distribution
Enzo Biochem, of New York, NY, said yesterday that it would buy Axxora Life Sciences, a private company based in San Diego that makes life sciences research products, for $16.3 million in cash. Once the deal goes through, Axxora will become a wholly owned subsidiary of Enzo’s Enzo Life Sciences subsidiary, which makes labeling and detection products […]
Telemedicine Addresses Rising Healthcare Costs
A recent article in The New York Times discusses TeleStroke, a telemedicine program being offered by Brigham and Women’s and Massachusetts General Hospitals in Boston. The program is designed to help hospitals that do not have the resources to employ expensive stroke specialists and as a result, are not equipped to make decisions about administering […]
FDA Green Lights Harvest’s Stem Cell Trial
Harvest Technologies, a Plymouth, MA, company that uses stem cells from bone marrow to treat critical limb ischemia, received the go-ahead yesterday from FDA to start a 48-patient trial for the company’s Bone Marrow Aspirate Concentrate (BMAC) System. If all goes as planned, Harvest expects the device to hit the market sometime in 2010.
The BMAC […]
Next-Generation Psych Treatments
An article published yesterday in Technology Review discusses two new technologies being developed to improve psychiatric treatment.
The first, from Norwood, MA-based Aspect Medical Systems, is a device that predicts whether an antidepressant is taking effect, after just one week. Typically, patients have to wait several weeks or months for psych meds to start working. But […]
BioElectronics Expands International Distribution
BioElectronics, a Frederick, MD, company that makes anti-inflammatory patches, signed a deal last week with Eximeq for the Mexican healthcare-services provider to distribute BioElectronics’ ActiPatch south of the border. ActiPatch delivers pulsed electromagnetic frequency (PEMF) to accelerate healing of soft tissue injuries. PEMF has been shown to reduce pain and swelling by lessening the body’s inflammatory […]
Endocare Raises $7 Million
Endocare, an Irvine, CA-based company focused on tissue and tumor ablation, has raised $7 million in a private placement of common stock to Seattle-based Frazier Healthcare Ventures. In a statement, Endocare CEO Craig Davenport said the money will go toward the company’s development efforts in prostate and renal cancer cryoablation, and toward expanding its presence in […]
New Device Outpaces Competition in Epilepsy Market
A new device for epilepsy patients being developed by Mountain View, CA-based NeuroPace was featured this week in Technology Review. The company’s responsive neurostimulation (RNS) system is designed to help epilepsy patients who are unresponsive to drugs. NeuroPace estimates that about 2.5 million Americas are affected by epilepsy, and roughly 40-50% of those are either […]
Regional Group Supports Pittsburgh Startup
Pittsburgh Life Sciences Greenhouse, an organization that invests in up-and-coming biosciences companies in Southwestern Pennsylvania, has committed $150,000 to Celsense, a local company that was founded in 2005 to commercialize imaging platforms licensed from Carnegie Mellon University.
The privately held company will put the money toward bringing to market is flagship product, Cell Sense, an MRI […]
Chembio to Develop Tests for Leishmaniasis and Leprosy
Chembio Diagnostic Systems, of Medford, NY, is teaming up with the Infectious Disease Research Institute (IDRI) to develop rapid diagnostic tests for two neglected diseases, Leishmaniasis and Leprosy. Chembio will develop the tests using its Dual Path Platform (DPP) technology, for which it was awarded a U.S. patent in March, and incorporating IDRI proprietary antigens. […]
Inovio’s Delivery Technology Boosts Cancer Vax Potency
Data released yesterday from a study of an experimental prostate cancer vaccine showed that Inovio Biomedical’s delivery system significantly enhanced the vaccine’s potency. In the Phase I/II study, some patients received the vaccine through Inovio’s electroporation technology, which uses brief, controlled electrical pulses to increase cellular uptake of gene expression in DNA-based treatments; this enhances […]
